n(1)-methylnicotinamide has been researched along with Chronic Disease in 3 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Depression is one of the most common psychiatric disorders, and there is strong demand for developing novel antidepressants with better efficacy and less adverse effects." | 1.62 | Antidepressant-like effects of 1-methylnicotinamide in a chronic unpredictable mild stress model of depression. ( Gu, JH; Ji, CH; Jiang, B; Liu, Y; Tang, WQ; Zhang, Y; Zhao, J, 2021) |
| "Rosacea is a chronic facial dermatosis with a progressive course, which is characterized by the presence of erythema, papules, pustules, telangiectasias and sebaceous gland hyperplasia." | 1.33 | Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. ( Gebicki, J; Sysa-Jedrzejowska, A; Wieczorkowska, M; Wozniacka, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, S | 1 |
| Ma, Y | 1 |
| Hao, L | 1 |
| Ding, Q | 1 |
| Chang, K | 1 |
| Zhuge, H | 1 |
| Qiu, J | 1 |
| Xu, T | 1 |
| Dou, X | 1 |
| Li, S | 1 |
| Zhao, J | 1 |
| Zhang, Y | 1 |
| Liu, Y | 1 |
| Tang, WQ | 1 |
| Ji, CH | 1 |
| Gu, JH | 1 |
| Jiang, B | 1 |
| Wozniacka, A | 1 |
| Wieczorkowska, M | 1 |
| Gebicki, J | 1 |
| Sysa-Jedrzejowska, A | 1 |
3 other studies available for n(1)-methylnicotinamide and Chronic Disease
| Article | Year |
|---|---|
1-Methylnicotinamide promotes hepatic steatosis in mice: A potential mechanism in chronic alcohol-induced fatty liver disease.
Topics: Animals; Chronic Disease; Ethanol; Fatty Liver; Fatty Liver, Alcoholic; Mice; Mice, Inbred C57BL; St | 2023 |
Antidepressant-like effects of 1-methylnicotinamide in a chronic unpredictable mild stress model of depression.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chronic Disease; Depression; Dise | 2021 |
Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study.
Topics: Administration, Topical; Adult; Chronic Disease; Dermatologic Agents; Facial Dermatoses; Female; Gel | 2005 |